Centric Health Corp. (TSE:CRX – Free Report) – Stock analysts at Desjardins issued their Q3 2024 earnings estimates for Centric Health in a research report issued on Wednesday, October 30th. Desjardins analyst G. Ho forecasts that the company will post earnings of $0.00 per share for the quarter.
Other analysts also recently issued research reports about the stock. Stifel Canada downgraded shares of Centric Health from a “strong-buy” rating to a “hold” rating in a report on Monday, August 12th. Ventum Cap Mkts raised Centric Health to a “strong-buy” rating in a research note on Thursday, August 8th.
Centric Health Stock Performance
Centric Health (TSE:CRX – Get Free Report) last posted its quarterly earnings data on Thursday, August 8th. The company reported C($0.02) EPS for the quarter, missing the consensus estimate of C($0.01) by C($0.01). The company had revenue of C$91.97 million during the quarter, compared to analysts’ expectations of C$91.10 million.
See Also
- Five stocks we like better than Centric Health
- How to Invest in Small Cap Stocks
- Energy Vault Soars 100%: CEO Shares Why in MarketBeat Exclusive
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Meta’s Q3 Earnings Beat—Is This Dip a Golden Entry Opportunity?
- Find and Profitably Trade Stocks at 52-Week Lows
- Top Nuclear Stocks Thriving on Soaring Energy Demand
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
